Articular Cartilage: From Formation to Tissue Engineering|
The authors summarize the current state of cartilage tissue engineering in the context of relevant biological aspects, such as the formation and growth of hyaline cartilage, its composition, structure and biomechanical properties. Special attention is given to materials development, scaffold designs, fabrication methods, and template–cell interactions, which are of great importance to the structure and functionality of the engineered tissue. [Biomater Sci] Abstract
Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.
First Allogeneic Cell Therapy Product Launched in Japan by Mesoblast Licensee|
Mesoblast Limited announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., launched its mesenchymal stem cell product TEMCELL® HS Inj., for the treatment of acute graft versus host disease in children and adults in Japan. [Mesoblast Ltd] Press Release
Creative Medical Health Inc. Announces Creation of AngioStem Inc. Subsidiary to Commercialize Issued Cardiovascular Stem Cell Patent
Creative Medical Health announced formation of a subsidiary company, AngioStem Inc., dedicated to commercialization of its cardiovascular assets, including issued US patent #9,205,112, titled “Combination Therapy of Cardiovascular Disease.” [Creative Medical Health, Inc. (Business Wire)] Press Release
From our sponsor:
Webinar: Neural Stem Cell Culture Systems – Neurosphere vs. Adherent Monolayer Culture. Watch now.
NEW NYSTEM 2016|
May 10-11, 2016
New York City, United States
Visit our events page to see a complete list of events in the mesenchymal cell community.